FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance

For many years, disappointing results have been generated by many investigations, which have utilized a variety of immunologic strategies to enhance the ability of a patient’s immune system to recognize and eliminate malignant cells. However, in recent years, immunotherapy has been used successfully...

Descripción completa

Detalles Bibliográficos
Autores principales: Caratelli, Sara, Sconocchia, Tommaso, Arriga, Roberto, Coppola, Andrea, Lanzilli, Giulia, Lauro, Davide, Venditti, Adriano, Del Principe, Maria Ilaria, Buccisano, Francesco, Maurillo, Luca, Ferrone, Soldano, Sconocchia, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406408/
https://www.ncbi.nlm.nih.gov/pubmed/28496440
http://dx.doi.org/10.3389/fimmu.2017.00457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406408/
https://www.ncbi.nlm.nih.gov/pubmed/28496440
http://dx.doi.org/10.3389/fimmu.2017.00457

Ejemplares similares